Corrigendum to “Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017)” [EClinicalMedicine 18 (2020) 100238]

作者：Lulu Zuo, Kai Liu, Honglian Liu, Yihong Hu, Zhijie Zhang, Jianru Qin, Qinggang Xu, Ke Peng, Xia Jin, Jianhua Wang, Chiyu Zhang · 发表于：EClinicalMedicine · 年份：2021 · DOI：10.1016/j.eclinm.2020.100696 · 被引用次数：9 · 研究领域：HIV Research and Treatment、HIV/AIDS drug development and treatment、Pneumocystis jirovecii pneumonia detection and treatment

The authors regret that the published version of this article contained errors in Fig. 3, Appendix 19, mmc1 and mmc2 as corrigendum. We provided the corrected Fig. 3, Appendix 19 and descriptions below and reconfirmed all information of mmc1 and mmc2. We highlighted the corrected median sampling year in the new table (Supplementary Corrigendum Table). So the trend of transmitted drug resistance (NRTI, NNRTI, PI) in different regions of China changed accordingly as showed below. The mistakes do not affect the temporal trend of drug resistance prevalence in ART-naive individuals with HIV, and the corrections do not change the interpretation, and conclusions of the paper.